Antiretroviral therapy is frequently associated with adverse metabolic effects and lipodystrophy, but the role of HIV protease inhibitors and the mechanisms involved are poorly understood. The HIV protease inhibitor nelfinavir (NFV) impairs insulin signal propagation by inducing similar signalling defects to those induced by exposure to oxidative stress.
Aim
We set out to determine if oxidative stress is involved in NFV-induced insulin resistance in 3T3-L1 adipocytes, and whether antioxidant agents with unique modes of action can prevent this effect.
Results
Cells exposed to NFV exhibited the following markers of increased oxidative stress: a decrease in both total and low molecular weight reduced thiols, a 20-fold increase in haem oxygenase 1 (HO-1) mRNA, an increase in intracellular reactive oxygen species production (determined by 2′,7′-dichlorofluorescein fluorescence), and increased markers of apoptosis. Enhancing cellular thiols with N-acetylcystein prevented the NFV-induced drop in reduced thiols and partially protected against the induction in HO-1, but failed to prevent insulin resistance or cleavage of poly ADP ribose polymerase (PARP), a process indicative of activation of pro-apoptotic caspases.
Conversely, the superoxide dismutase-mimetic antioxidant MnTBAP had no effect on cellular thiols in response to NFV, but protected against HO-1 induction and against the impairment in insulin-stimulated Akt/protein kinase B activation and PARP cleavage.
Conclusions
Induction of oxidative stress plays a role in adipocyte insulin resistance and apoptosis induced by NFV through a radical-dependent but thiol-independent mechanism(s). The results may suggest a new mechanism for the adverse effects of NFV on fat cells, and offer potential new intervention approaches.
References
1.
CarrA., SamarasK., BurtonS.A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.AIDS1998; 12: F51–58.
2.
GrahamN.M.Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review.J Acquir Immune Defic Syndr2000; 25 (Suppl 1): S4–11.
3.
GrinspoonS.Insulin resistance in the HIV-lipodystrophy syndrome.Trends Endocrinol Metab2001; 12: 413–419.
4.
HeathK.V., HoggR.S., ChanK.J.Lipodystrophy-associ-ated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database.AIDS2001; 15: 231–239.
5.
ShevitzA., WankeC.A., FalutzJ., KotlerD.P.Clinical perspectives on HIV-associated lipodystrophy syndrome: an update.AIDS2001; 15: 1917–1930.
6.
WoerleH.J., MariuzP.R., MeyerC.Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.Diabetes2003; 52: 918–925.
7.
MaggiP., SerioG., EpifaniG.Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors.AIDS2000; 14: F123–128.
8.
BarbaroG., Di LorenzoG., CirelliA.An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy.Clin Ther2003; 25: 2405–2418.
9.
CarrA., SamarasK., ChisholmD.J., CooperD.A.Abnormal fat distribution and use of protease inhibitors.Lancet1998; 351: 1736.
10.
NoorM.A., LoJ.C., MulliganK.Metabolic effects of indinavir in healthy HIV-seronegative men.AIDS2001; 15: F11–18.
11.
RudichA., Ben-RomanoR., EtzionS., BashanN.Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors.Acta Physiol Scand2005; 183: 75–88.
12.
HruzP.W., MurataH., QiuH., MuecklerM.Indinavir induces acute and reversible peripheral insulin resistance in rats.Diabetes2002; 51: 937–942.
13.
MurataH., HruzP.W., MuecklerM.The mechanism of insulin resistance caused by HIV protease inhibitor therapy.J Biol Chem2000; 275: 20251–20254.
14.
RudichA., KonradD., TorokD.Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues.Diabetologia2003; 46: 649–658.
15.
DowellP., FlexnerC., KwiterovichP.O., LaneM.D.Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors.J Biol Chem2000; 275: 41325–41332.
16.
VincentS., TourniaireF., El YazidiC.M.Nelfinavir induces necrosis of 3T3F44–2A adipocytes by oxidative stress.J Acquir Immune Defic Syndr2004; 37: 1556–1562.
ZhangB., MacNaulK., SzalkowskiD.Inhibition of adipocyte differentiation by HIV protease inhibitors.J Clin Endocrinol Metab1999; 84: 4274–4277.
19.
LagathuC., BastardJ.P., AuclairM.Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.Antivir Ther2004; 9: 911–920.
20.
Ben-RomanoR., RudichA., TiroshA.Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKCζ.Diabetologia2004; 47: 1107–1117.
21.
RudichA., VanounouS., RiesenbergK.The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes.Diabetes2001; 50: 1425–1431.
EvansJ.L., GoldfineI.D., MadduxB.A., GrodskyG.M.Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.Endocr Rev2002; 23: 599–622.
24.
HoustisN., RosenE.D., LanderE.S.Reactive oxygen species have a causal role in multiple forms of insulin resistance.Nature2006; 440: 944–948.
25.
Bloch-DamtiA., BashanN.Proposed mechanisms for the induction of insulin resistance by oxidative stress.Antioxid Redox Signal2005; 7: 1553–1567.
26.
HansenL.L., IkedaY., OlsenG.S., BuschA.K., MosthafL.Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance.J Biol Chem1999; 274: 25078–25084.
27.
LinY., BergA.H., IyengarP.The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species.J Biol Chem2005; 280: 4617–4626.
28.
TiroshA., PotashnikR., BashanN., RudichA.Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes.J Biol Chem1999; 274: 10595–10602.
29.
AukrustP., MullerF., SvardalA.M.Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy - potential immunomodulatory effects of antioxidants.J Infect Dis2003; 188: 232–238.
30.
MondalD., PradhanL., AliM., AgrawalK.C.HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants.Cardiovasc Toxicol2004; 4: 287–302.
31.
Ben-RomanoR., RudichA., TorokD.Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors.AIDS2003; 17: 23–32.
32.
TiroshA., RudichA., PotashnikR., BashanN.Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adipocytes.Biochem J2001; 355: 757–763.
33.
BradfordM.M.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem1976; 72: 248–254.
34.
HadariY.R., TzaharE., NadivO.Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3′-kinase upon its association with pp185 (IRS-1) in intact rat livers.J Biol Chem1992; 267: 17483–17486.
35.
JakubowskiW., BartoszG.2,7-dichlorofluorescin oxidation and reactive oxygen species: what does it measure?Cell Biol Int2000; 24: 757–760.
36.
BeutlerE. (editor). Red cell metabolism. A manual of biochemical methods, 2nd edn 1975. New York: Grune and Stratton.
37.
KozlovskyN., RudichA., PotashnikR.Transcriptional activation of the Glut1 gene in response to oxidative stress in L6 myotubes.J Biol Chem1997; 272: 33367–33372.
38.
NakamuraH., MasutaniH., YodoiJ.Redox imbalance and its control in HIV infection.Antioxid Redox Signal2002; 4: 455–464.
39.
JannehO., HoggardP.G., TjiaJ.F.Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes.Antivir Ther2003; 8: 417–426.
40.
VernochetC., AzoulayS., DuvalD.Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines.J Biol Chem2005; 280: 2238–2243.
41.
Carvalho-FilhoM.A., UenoM., HirabaraS.M.S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance.Diabetes2005; 54: 959–967.
42.
Bloch-DamtiA., PotashnikR., GualP.Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress.Diabetologia2006; 49: 2463–2473.
43.
EvansJ.L., GoldfineI.D., MadduxB.A., GrodskyG.M.Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?Diabetes2003; 52: 1–8.
44.
SoaresA.F., GuichardantM., CozzoneD.Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes.Free Radic Biol Med2005; 38: 882–889.
45.
FurukawaS., FujitaT., ShimabukuroM.Increased oxidative stress in obesity and its impact on metabolic syndrome.J Clin Invest2004; 114: 1752–1761.
46.
KhamaisiM., KavelO., RosenstockM.Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoximine.Biochem J2000; 349: 579–586.
